EXEL Exelixis Inc.

$29.125 +0.47%

1,655,563 Shares Traded
2,668,365 Average Volume (last 30 days)

as of February 22, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $2.18 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:7.68%
If Intiated One Month Ago, Shorts Have Realized a Return of:1.53%
If Initiated Five Days ago, Shorts Have Realized a Return of:1.86%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 5.55%
Short Interest16.14 million
Float291.01 million
Short Ratio5.28
Market Cap$8.58 billion
Market Maker ActivityDaily Short Volume


3 Things In Biotech You Should Learn Today: February 14, 2018 (SeekingAlpha)
Exelixis to Present at the RBC Capital Markets Global Healthcare Conference on February 21, 2018 (Business Wire)
Exelixis Announces Results from a Phase 2 Investigator-Sponsored Trial of Cabozantinib in the First-Line Treatment of Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma (Business Wire)
3 Things In Biotech You Should Learn Today: February 9, 2018 (SeekingAlpha)
Key events next week - healthcare (SeekingAlpha)
Exelixis to Release Fourth Quarter and Full Year 2017 Financial Results on Monday, February 26, 2018 (Business Wire)
Your Daily Pharma Scoop: Abeona Surges, Gilead Results, Biogen Setback (SeekingAlpha)
Exelixis' Cabometyx shows treatment benefit in early-stage genitourinary tumor study; shares up 1% (SeekingAlpha)
Exelixis Announces Updated Phase 1 Trial Results for Cabozantinib in Combination with Nivolumab with or without Ipilimumab in Refractory Genitourinary (GU) Tumors (Business Wire)
Exelixis to Present at the Leerink Partners Global Healthcare Conference on February 14 (Business Wire)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 88.4%

Earnings Stats

PE Ratio 57.06
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $26.02
50 Day Moving Average $29.21
52 Week High $32.5
52 Week Low $18.03

Data provided for free by IEX. Questions? Read the FAQ